Next Article in Journal
NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling
Next Article in Special Issue
Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma
Previous Article in Journal
Conventional vs. Drug-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma—A Propensity Score Weighted Comparison of Efficacy and Safety
Previous Article in Special Issue
Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence
 
 
Article

Article Versions Notes

Cancers 2022, 14(23), 5848; https://doi.org/10.3390/cancers14235848
Action Date Notes Link
article xml file uploaded 27 November 2022 11:38 CET Original file -
article xml uploaded. 27 November 2022 11:38 CET Update https://www.mdpi.com/2072-6694/14/23/5848/xml
article pdf uploaded. 27 November 2022 11:38 CET Version of Record https://www.mdpi.com/2072-6694/14/23/5848/pdf
article supplementary file uploaded. 27 November 2022 11:38 CET - https://www.mdpi.com/2072-6694/14/23/5848#supplementary
article html file updated 27 November 2022 11:39 CET Original file -
article html file updated 3 March 2023 23:20 CET Update https://www.mdpi.com/2072-6694/14/23/5848/html
Back to TopTop